State legislative trends related to biomarker testing-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

State legislative trends related to biomarker testing

Published:2022-05-24 Issue:15 Volume:128 Page:2865-2870
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Sadigh Gelareh¹^ORCID,Goeckner Hilary Gee²,Kazerooni Ella A.³⁴^ORCID,Johnson Bruce E.⁵,Smith Robert A.⁶^ORCID,Adams Devon V.²,Carlos Ruth C.³^ORCID

Affiliation:

1. Department of Radiology and Imaging Sciences Emory University School of Medicine Atlanta Georgia USA

2. American Cancer Society Cancer Action Network, Inc Washington District of Columbia USA

3. Department of Radiology University of Michigan Ann Arbor Michigan USA

4. Department of Internal Medicine University of Michigan Ann Arbor Michigan USA

5. Department of Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts USA

6. Early Cancer Detection Science American Cancer Society Atlanta Georgia USA

Funder

National Comprehensive Cancer Network

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.34271

Reference50 articles.

1. Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer

2. NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology

3. Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study

4. Clinical Impact of Adherence to NCCN Guidelines for Biomarker Testing and First-Line Treatment in Advanced Non-Small Cell Lung Cancer (aNSCLC) Using Real-World Electronic Health Record Data

5. Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarker Testing Disparities in Metastatic Colorectal Cancer;JAMA Network Open;2024-07-05

2. The State of State Biomarker Testing Insurance Coverage Laws;JAMA;2024-06-11

3. Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology;Journal of Clinical Oncology;2024-04-01

4. A local perspective on internal, external, and reflexive biomarker testing processes for lung cancer in an academic medical center;Cancer;2024-02-14

5. Real-world Trends, Rural-urban Differences, and Socioeconomic Disparities in Utilization of Narrow versus Broad Next-generation Sequencing Panels;Cancer Research Communications;2024-02-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3